|
|
 |
|  |
|
Home > Drug Companies > Collagenex Pharmaceuticals, Inc.
Collagenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on providing innovative medical therapies for dermatological diseases. CollaGenex is developing dermatological applications of its proprietary IMPACS technology. Oracea has completed Phase III clinical trials for the treatment of the inflammatory lesions of rosacea.
A drug manufacturer is a business entity engaged in making, assembling, processing or modifying devices, or mixing, producing or preparing drugs in dosage forms by encapsulating, entableting or other process, or packaging, repackaging or otherwise changing the container, wrapper or label of any package containing a drug or device in furtherance of the distribution of the drug or device from the original place of manufacture to the person who makes final delivery or sale to the ultimate consumer.
A new Drug Application NDA for Oracea was submitted to the FDA on July 31, 2005. Incyclinide formerly known as Col-3 is in Phase II clinical trials for the treatment of acne. CollaGenex is developing additional products for dermatology based on Restoraderm, a novel drug delivery technology. CollaGenex markets a portfolio of products for the dermatology market.
CollaGenex currently markets products to the dermatological field of medicine. The CollaGenex portfolio of products is currently composed of established, in-licensed products, such as Pandel, as well as co marketed products, such as Alcortin and Novacort. Future dermatology products will be based on the unique properties of the IMPACS technology platform and the Restoraderm drug delivery technology. Both IMPACS and Restoraderm are proprietary technologies of CollaGenex. CollaGenex is a dynamic and rapidly growing specialty pharmaceutical company. Their mission is to develop and market innovative medical therapies for targeted disease classes in high potential markets, such as dentistry and dermatology. To achieve their goals, they've assembled a team of talented, experienced, and dedicated individuals who enjoy what they do.
Back to Drug Companies
|
|
 |
|
 |
|
|
|